Access the full text.
Sign up today, get DeepDyve free for 14 days.
Inés Castro, J. Cubiella, Concepción Rivera, Carmen González-Mao, P. Vega, S. Soto, V. Hernández, Felipe Iglesias, María Alves, L. Bujanda, J. Fernández-Seara (2014)
Fecal immunochemical test accuracy in familial risk colorectal cancer screeningInternational Journal of Cancer, 134
Z. Levi, P. Rozen, R. Hazazi, A. Vilkin, Amal Waked, E. Maoz, S. Birkenfeld, M. Leshno, Y. Niv (2007)
A Quantitative Immunochemical Fecal Occult Blood Test for Colorectal NeoplasiaAnnals of Internal Medicine, 146
JL Brozek, EA Akl, P Alonso-Coello (2009)
Grading quality of evidence and strength of recommendations in clinical practice guidelines: part 1 of 3. an overview of the GRADE approach and grading quality of evidence about interventions, 64
Yan-fei Jiang, Guoxiang Liu, Hui-Yao Huang, Weidong Huang, Xin Zhang, Wenqi Fu, M. Dai, Jufang Shi (2015)
[Accuracy of immunochemical faecal occult blood test for colorectal cancer: meta-analysis].Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine], 49 5
K. Bibbins-Domingo, D. Grossman, S. Curry, K. Davidson, J. Epling, Francisco García, M. Gillman, D. Harper, A. Kemper, A. Krist, A. Kurth, C. Landefeld, C. Mangione, D. Owens, W. Phillips, M. Phipps, M. Pignone, A. Siu (2016)
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.JAMA, 315 23
C. Rutter, C. Gatsonis (2001)
A hierarchical regression approach to meta‐analysis of diagnostic test accuracy evaluationsStatistics in Medicine, 20
D. Robertson, Jeffrey-K Lee, C. Boland, J. Dominitz, F. Giardiello, David Johnson, T. Kaltenbach, D. Lieberman, T. Levin, D. Rex (2017)
Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on colorectal cancer.Gastrointestinal endoscopy, 85 1
F. Amersi, M. Agustin, C. Ko (2005)
Colorectal cancer: epidemiology, risk factors, and health services.Clinics in colon and rectal surgery, 18 3
E. Quintero, M. Carrillo, A. Gimeno-García, M. Hernández‐Guerra, D. Nicolás-Pérez, I. Alonso-Abreu, María Díez-Fuentes, V. Abraira (2014)
Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.Gastroenterology, 147 5
P. Bossuyt, J. Reitsma, K. Linnet, K. Moons (2013)
Beyond diagnostic accuracy: the clinical utility of diagnostic tests.Clinical chemistry, 58 12
T. Wijkerslooth, M. Haan, E. Stoop, P. Bossuyt, M. Thomeer, M. Leerdam, M. Essink‐bot, P. Fockens, E. Kuipers, J. Stoker, E. Dekker (2012)
Reasons for Participation and Nonparticipation in Colorectal Cancer Screening: A Randomized Trial of Colonoscopy and CT ColonographyThe American Journal of Gastroenterology, 107
H. Salimzadeh, F. Bishehsari, Mohammad Amani, R. Ansari, M. Sotoudeh, A. Delavari, R. Malekzadeh (2016)
Advanced colonic neoplasia in the first degree relatives of colon cancer patients: A colonoscopy‐based studyInternational Journal of Cancer, 139
M. Wong, J. Ching, V. Chan, Thomas Lam, A. Luk, S. Ng, J. Sung (2015)
Factors associated with false-positive and false-negative fecal immunochemical test results for colorectal cancer screening.Gastrointestinal endoscopy, 81 3
C. Fraser, J. Allison, S. Halloran, G. Young (2012)
A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin.Journal of the National Cancer Institute, 104 11
L. Rossum, A. Rijn, R. Laheij, M. Oijen, P. Fockens, H. Krieken, A. Verbeek, J. Jansen, E. Dekker (2008)
Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.Gastroenterology, 135 1
D. Moher, A. Liberati, J. Tetzlaff, D. Altman (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA StatementOpen Medicine, 3
S. Ng, J. Ching, V. Chan, M. Wong, B. Suen, H. Hirai, T. Lam, J. Lau, S. Ng, Justin Wu, F. Chan, J. Sung (2013)
Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancerAlimentary Pharmacology & Therapeutics, 38
B. Berger, Marcus Parton, B. Levin (2016)
USPSTF colorectal cancer screening guidelines: an extended look at multi-year interval testing.The American journal of managed care, 22 2
A. Gimeno-García, M. Carrillo-Palau, M. Hernández‐Guerra, D. Nicolás-Pérez, I. Alonso-Abreu, A. Jiménez-Sosa, E. Quintero (2011)
Diagnostic Yield of the Immunochemical Fecal Occult Blood Test in Asymptomatic First Degree Relatives of Colorectal Cancer PatientsGastroenterology, 140
C. Arditi, J. Gonvers, B. Burnand, G. Minoli, D. Oertli, F. Lacaine, R. Dubois, J. Vader, S. Filliettaz, I. Peytremann-Bridevaux, V. Pittet, P. Juillerat, F. Froehlich (2009)
Appropriateness of colonoscopy in Europe (EPAGE II) – Surveillance after polypectomy and after resection of colorectal cancerEndoscopy, 41
小島原典子, 森實敏夫, 中山健夫, 福岡敏雄, 河合富士美, 佐藤康仁, 吉田雅博, 山口直人 (2014)
診断精度研究のバイアスリスク評価ツールQUADAS-2:a Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies 2 の活用
D. Moher, A. Liberati, J. Tetzlaff, D. Altman (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA StatementPLoS Medicine, 6
M. Parekh, A. Fendrick, U. Ladabaum (2008)
As tests evolve and costs of cancer care rise: reappraising stool‐based screening for colorectal neoplasiaAlimentary Pharmacology & Therapeutics, 27
J. Reitsma, A. Glas, A. Rutjes, R. Scholten, P. Bossuyt, A. Zwinderman (2005)
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews.Journal of clinical epidemiology, 58 10
J. Deeks, D. Altman (2004)
Diagnostic tests 4: likelihood ratiosBMJ : British Medical Journal, 329
E. Quintero, A. Castells, L. Bujanda, J. Cubiella, D. Salas, Á. Lanas, M. Andreu, F. Carballo, J. Morillas, C. Hernández, R. Jover, I. Montalvo, J. Arenas, Eva Laredo, V. Hernández, Felipe Iglesias, E. Cid, R. Zubizarreta, T. Sala, M. Ponce, M. Andrés, Gloria Teruel, A. Peris, María Roncalés, M. Polo-Tomás, X. Bessa, Olga Ferrer-Armengou, J. Grau, A. Serradesanferm, A. Ono, J. Cruzado, F. Pérez-Riquelme, I. Alonso-Abreu, Mariola Vega-Prieto, Juana Reyes-Melian, G. Cacho, J. Diaz-Tasende, A. Herreros-de-Tejada, C. Poves, C. Santander, A. González-Navarro (2012)
Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening.The New England journal of medicine, 366 8
A. Gimeno-García, E. Quintero, D. Nicolás-Pérez, M. Hernández‐Guerra, A. Parra-Blanco, A. Jiménez-Sosa (2009)
Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot studyEuropean Journal of Gastroenterology & Hepatology, 21
D. Fisher, J. Maple, T. Ben-Menachem, B. Cash, G. Decker, D. Early, John Evans, R. Fanelli, N. Fukami, J. Hwang, R. Jain, Terry Jue, K. Khan, P. Malpas, R. Sharaf, A. Shergill, J. Dominitz (2003)
Complications of ColonoscopyAnnals of Internal Medicine, 145
J. Brożek, E. Akl, P. Alonso-Coello, David Lang, Roman Jaeschke, John Williams, B. Phillips, M. Lelgemann, A. Lethaby, J. Bousquet, G. Guyatt, H. Schünemann (2009)
Grading quality of evidence and strength of recommendations in clinical practice guidelinesAllergy, 64
Z. Levi, S. Birkenfeld, A. Vilkin, M. Bar-Chana, I. Lifshitz, Miri Chared, E. Maoz, Y. Niv (2011)
A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility studyInternational Journal of Cancer, 128
Y Jiang, G Liu, H Huang (2015)
Accuracy of immunochemical faecal occult blood test for colorectal cancer: meta-analysis [article in Chinese], 49
JK Lee, EG Liles, S Bent, TR Levin, DA Corley (2014)
Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis, 160
F. Oort, J. Droste, R. Hulst, H. Heukelem, R. Loffeld, I. Wesdorp, R. Wanrooij, L. Baaij, E. Mutsaers, S. Reijt, V. Coupé, J. Berkhof, A. Bouman, G. Meijer, Cjj Mulder (2010)
Colonoscopy‐controlled intra‐individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac‐based faecal occult blood testAlimentary Pharmacology & Therapeutics, 31
J. Brożek, E. Akl, Roman Jaeschke, David Lang, P. Bossuyt, P. Glasziou, M. Helfand, Erin Ueffing, P. Alonso-Coello, Joerg Meerpohl, Bob Phillips, A. Horvath, J. Bousquet, G. Guyatt, H. Schünemann, H. Schünemann (2009)
Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategiesAllergy, 64
Jeffrey-K Lee, Elizabeth Liles, S. Bent, T. Levin, D. Corley (2014)
Accuracy of Fecal Immunochemical Tests for Colorectal CancerAnnals of Internal Medicine, 160
B. Levin, D. Lieberman, B. McFarland, Robert Smith, D. Brooks, Kimberly Andrews, C. Dash, F. Giardiello, S. Glick, T. Levin, Perry Pickhardt, D. Rex, A. Thorson, S. Winawer (2008)
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology * †CA: A Cancer Journal for Clinicians, 58
C. Bacchus, L. Dunfield, S. Gorber, Nathalie Holmes, Richard Birtwhistle, J. Dickinson, G. Lewin, Harminder Singh, S. Klarenbach, V. Mai, M. Tonelli (2016)
Recommendations on screening for colorectal cancer in primary careCanadian Medical Association Journal, 188
M. Carroll, H. Seaman, S. Halloran (2014)
Tests and investigations for colorectal cancer screening.Clinical biochemistry, 47 10-11
R. Hazazi, Paul Rozen, Paul Rozen, Moshe Leshno, Z. Levi, Z. Samuel, Amal Waked, A. Vilkin, E. Maoz, S. Birkenfeld, Y. Niv, Y. Niv (2010)
Can patients at high risk for significant colorectal neoplasms and having normal quantitative faecal occult blood test postpone elective colonoscopy?Alimentary Pharmacology & Therapeutics, 31
Gowri Gopalakrishna, R. Mustafa, C. Davenport, R. Scholten, C. Hyde, J. Brożek, H. Schünemann, P. Bossuyt, M. Leeflang, M. Langendam (2014)
Applying Grading of Recommendations Assessment, Development and Evaluation (GRADE) to diagnostic tests was challenging but doable.Journal of clinical epidemiology, 67 7
J. Brożek, E. Akl, E. Akl, E. Compalati, J. Kreis, Luigi Terracciano, A. Fiocchi, Erin Ueffing, J. Andrews, P. Alonso-Coello, Joerg Meerpohl, David Lang, Roman Jaeschke, John Williams, B. Phillips, A. Lethaby, P. Bossuyt, P. Glasziou, M. Helfand, J. Watine, M. Afilalo, V. Welch, A. Montedori, I. Abraha, A. Horvath, J. Bousquet, G. Guyatt, H. Schünemann (2011)
Grading quality of evidence and strength of recommendations in clinical practice guidelines Part 3 of 3. The GRADE approach to developing recommendationsAllergy, 66
L. Rossum, A. Rijn, A. Verbeek, M. Oijen, R. Laheij, P. Fockens, J. Jansen, E. Adang, E. Dekker (2011)
Colorectal cancer screening comparing no screening, immunochemical and guaiac fecal occult blood tests: A cost‐effectiveness analysisInternational Journal of Cancer, 128
Jillian Henderson, Elizabeth Webber, G. Sawaya (2016)
Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task ForceJAMA, 319
J. Droste, S. Turenhout, F. Oort, R. Hulst, Vincent Steeman, U. Coblijn, L. Eem, Ruud Duijkers, A. Bouman, G. Meijer, A. Depla, P. Scholten, R. Loffeld, V. Coupé, C. Mulder (2012)
Faecal immunochemical test accuracy in patients referred for surveillance colonoscopy: a multi-centre cohort studyBMC Gastroenterology, 12
Olalla Otero-Estévez, L. Chiara, F. Rodríguez-Berrocal, M. Cadena, J. Cubiella, Inés Castro, Carmen González-Mao, V. Hernández, V. Martínez-Zorzano (2014)
Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical testBritish Journal of Cancer, 112
L. Bujanda, C. Sarasqueta, L. Zubiaurre, Á. Cosme, C. Muñoz, Araceli Sánchez, Cristina Martín, L. Titó, V. Piñol, A. Castells, X. Llor, R. Xicola, Elisenda Pons, J. Clofent, M. Castro, J. Cuquerella, E. Medina, A. Gutiérrez, J. Arenas, R. Jover (2007)
Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancerGut, 56
R. Harbord, P. Whiting (2009)
Metandi: Meta-analysis of Diagnostic Accuracy Using Hierarchical Logistic RegressionThe Stata Journal, 9
L. Hunt, P. Rooney, K. Bostock, M. Robinson, J. Hardcastle, N. Armitage (1997)
Chemical and immunological testing for faecal occult blood in screening subjects at risk of familial colorectal cancer.Gut, 40
ImportanceThe potential role of the fecal immunochemical test (FIT) for screening patients at increased risk for colorectal cancer (CRC) has not yet been elucidated. ObjectiveTo assess the diagnostic accuracy of FIT for CRC or advanced neoplasia (AN) in asymptomatic patients at above-average risk. Data SourcesMEDLINE, EMBASE, Cochrane Library, and gray literature sources through August 2016. Study SelectionDiagnostic studies evaluating the accuracy of FIT for CRC or AN in patients with a personal or familial history of CRC using colonoscopy as the reference standard. Data Extraction and SynthesisTwo authors (A.K. and P.P.) independently extracted data and evaluated study quality using the Quality Assessment of Diagnostic Accuracy Studies–2 tool, and evaluated the quality of the body of evidence by means of GRADE (Grading of Recommendations Assessment, Development, and Evaluation). Hierarchical models were used to synthesize available evidence. Main Outcomes and MeasuresThe primary outcome was the diagnostic performance of FIT for detecting CRC or AN. ResultsWe included 12 studies (6204 participants). Seven studies were deemed at high or unclear risk of bias. The average sensitivity of FIT for CRC was 93% (95% CI, 53%-99%), and the average specificity was 91% (95% CI, 89%-92%), yielding a positive likelihood ratio (LR+) of 10.30 (CI 7.7-13.9) and a negative likelihood ratio (LR−) of 0.08 (95% CI, 0.01-0.75) (GRADE: very low). The average sensitivity of FIT for AN was 48% (95% CI, 39%-57%); and the average specificity was 93% (95% CI, 91%-94%), yielding an LR+ of 6.55 (95% CI, 5.0-8.5) and an LR− of 0.57 (95% CI, 0.48-0.67) (GRADE: very low). Subgroup analyses indicated that FIT cutoff values between 15- and 25-μg/g feces provided the best combination of sensitivity and specificity for the diagnosis of CRC (93% and 94%, respectively). Quantitative and 1-sample FIT showed adequate test performance, but data on other FIT brands and multiple samples were insufficient. Conclusions and RelevanceThe FIT has high overall diagnostic accuracy for CRC but moderate accuracy for AN in patients at above-average personal or familial risk. Heterogeneity and wide confidence intervals limit the trustworthiness of our findings.
JAMA Internal Medicine – American Medical Association
Published: Aug 19, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.